GLOBAL RESEARCH ARCHIVE
Morning Comment Sweden-06/17/2026
Research evidence excerpt
Morning Comment Sweden-06/17/2026
Morning Comment Sweden
17 JUN 2026
Today’s research focus S&P 500 intraday
7,570
• ATCO.A - Atlas Copco - Buy, TP SEK 220 (205): We expect a sequential
uptick in Vacuum Technique in Q2 vs Q1 thanks to a continued strong 7,560
demand from global semiconductor manufacturers. In Compressor 7,550
Technique, a strong underlying demand in Process and Gas will show up 7,540
in y/y growth thanks to easier comps in Q2 vs Q1 while industrial
compressors remain slightly positive y/y but still on an absolute low level. 7,530
Also orders in Industrial and Power Technique are only marginally positive 7,520
(up 4-5%). However, peace in the Middle East could be the long-awaited 7,510
catalyst for a more broad-based industrial capex recovery and together
with booming Vacuum demand, we lift our estimates slightly for 2026/28 7,500 16:00 17:00 18:00 19:00 20:00 21:00
and continue to see Atlas Copco as one of our favorite picks in a scenario
of a global capex recovery. The Q2-report is due out July 16. LINK
US and Asia indices (at time of publication)
• SEDANA - Sedana Medical - Buy, TP SEK 18: Sedana just submitted the 1.00% 0.86%
NDA to the FDA. Next is a 60-day filing review, during which the FDA 0.64%
decides whether the application is complete enough to be accepted. If 0.50%
accepted, a PDUFA date will be assigned marking the deadline for a final
decision. Standard review time is 10 months, meaning a decision can be 0.00%
expected during the spring of 2027. This is an important milestone, -0.08%
especially given the repeated delays over the years. The application is -0.50%
now with the FDA, and the timeline no longer depends on Sedana. We -0.57%
would not be surprised to see shares up substantially today. LINK -1.00% -0.97%
-1.15%
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer